Collegium Pharmaceutical Inc (COLL)
34.25
+0.43
(+1.27%)
USD |
NASDAQ |
May 24, 16:00
34.98
+0.73
(+2.13%)
After-Hours: 20:00
Collegium Pharmaceutical Accounts Receivable (Quarterly): 174.69M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 174.69M |
| December 31, 2023 | 179.52M |
| September 30, 2023 | 181.85M |
| June 30, 2023 | 167.48M |
| March 31, 2023 | 179.13M |
| December 31, 2022 | 183.12M |
| September 30, 2022 | 195.40M |
| June 30, 2022 | 197.50M |
| March 31, 2022 | 166.34M |
| December 31, 2021 | 105.84M |
| September 30, 2021 | 149.00M |
| June 30, 2021 | 90.10M |
| March 31, 2021 | 93.16M |
| December 31, 2020 | 83.32M |
| September 30, 2020 | 76.47M |
| June 30, 2020 | 81.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 85.43M |
| December 31, 2019 | 72.95M |
| September 30, 2019 | 84.38M |
| June 30, 2019 | 81.28M |
| March 31, 2019 | 85.14M |
| December 31, 2018 | 77.95M |
| September 30, 2018 | 66.53M |
| June 30, 2018 | 68.38M |
| March 31, 2018 | 66.04M |
| December 31, 2017 | 9.969M |
| September 30, 2017 | 5.823M |
| June 30, 2017 | 4.877M |
| March 31, 2017 | 3.349M |
| December 31, 2016 | 2.129M |
| September 30, 2016 | 1.679M |
| June 30, 2016 | 2.952M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
72.95M
Minimum
Dec 2019
197.50M
Maximum
Jun 2022
131.41M
Average
127.42M
Median
Accounts Receivable (Quarterly) Benchmarks
| Inotiv Inc | 55.02M |
| Catalyst Pharmaceuticals Inc | 60.49M |
| Supernus Pharmaceuticals Inc | 147.73M |
| Aquestive Therapeutics Inc | 6.703M |
| NovaBay Pharmaceuticals Inc | 0.734M |